Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Translational Investigation of the Glutamatergic and GABAergic System in Schizophrenia - a Combined EEG-, FMRI-, Genetic, Serological and Cell Biological Study

NCT04655235 is registered in ClinicalTrials.gov with RWTH Aachen University as lead sponsor.

NCT NCT04655235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04655235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Translational Investigation of the Glutamatergic and GABAergic System in Schizophrenia - a Combined EEG-, FMRI-, Genetic, Serological and Cell Biological Study
Lead sponsor
RWTH Aachen University
Phase
Observational
Overall status
Recruiting
Start date
October 1, 2021
Completion date
March 31, 2030
Enrollment
600 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia